PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BGR | Ann: Sales to 30 July 2017 | 03/08/17 | 0 | 692 | |||
|
|||||||
BGR | Ann: Notice Pursuant to Listing Rule 7.12.1 | 27/07/17 | 0 | 822 | |||
|
|||||||
BGR | Ann: Briscoe Group Limited (“BGR”) – Ticker Code Change | 15:40 | 0 | 703 | |||
|
|||||||
BGR | Ann: Briscoe Group Change in Ticker Code | 15:06 | 0 | 712 | |||
|
|||||||
BGR | Ann: Briscoe Group ASX listing date | 17/07/17 | 0 | 1.0K | |||
|
|||||||
BGR | Ann: Notice Pursuant to Listing Rule 7.12.1 | 29/06/17 | 0 | 611 | |||
|
|||||||
BGR | Ann: Annual Meeting Results 23 May 2017 | 23/05/17 | 0 | 665 | |||
|
|||||||
BGR | Ann: Managing Director's Address to Annual Meeting 23 May 2017 | 23/05/17 | 0 | 634 | |||
|
See All Discussions